v3.25.4
Note 29 - Share-based Payments (Tables)
12 Months Ended
Dec. 31, 2025
Statement Line Items [Line Items]  
Explanation of effect of share-based payments on entity's financial position [text block]
  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Share-based payments related to employees & directors

 $15,345  $22,480  $17,781 

Share-based payments related to advisor(i)

     107   (11,608)

Other share-based payments

  628       

Total Share-based payments

 $15,973  $22,587  $6,173 
Disclosure of number and weighted average exercise prices of share options [text block]
  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 
      

Weighted

      

Weighted

      

Weighted

 
      

average

  

Number of

  

average

  

Number of

  

average

 
  

Options

  

exercise price

  

stock options

  

exercise price

  

stock options

  

exercise price

 

Outstanding at beginning of period

  4,944,061  $14.00   2,577,467  $25.76   1,163,597  $37.98 

Granted during the period

  1,458,858  $24.52   2,881,758  $14.00   1,575,234  $25.76 

Forfeited during the period

  (441,161) $17.67   (515,164) $14.00   (139,012) $25.76 

Modified during the period

    $     $   (22,352) $25.76 

Exercised during the period

  (116,551) $14.14     $     $ 

Outstanding at the end of period

  5,845,207  $18.10   4,944,061  $14.00   2,577,467  $25.76 

Exercisable at the end of period

  2,341,984                   
BMC1 Class B Incentive Units [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Outstanding at beginning of period

  8,856,384   9,574,468    

Granted during the year

        9,574,468 

Shares converted from Class B to Class A during the period

  (5,136,703)      

Cancelled during the period

     (718,084)   

Outstanding at the end of the period

  3,719,681   8,856,384   9,574,468 
BMC1 Class A Restricted Units [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Outstanding at beginning of the period

  4,787,234   4,787,234    

Granted during the year

        4,787,234 

Shares converted from Class B to Class A during the period

  5,136,703       

Outstanding as of period end

  9,923,937   4,787,234   4,787,234 
Restricted stock units [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Year Ended December 31,

 
  

2025

  

2024

  

2023

 

Outstanding at beginning of the period

  200,046   201,939   235,109 

Granted during the year

  33,111       

Forfeited during the year

     (1,893)  (45,009)

Released during the year

  (40,009)      

Modified during the year

        11,839 

Outstanding at end of the period

  193,148   200,046   201,939 
Advisor [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of share options [text block]
  

Year Ended December 31, 2025

  

Year Ended December 31, 2024

  

Year Ended December 31, 2023

 
      

Weighted

      

Weighted

      

Weighted

 
      

average

      

average

      

average

 
  

Options

  

exercise price

  

Options

  

exercise price

  

Options

  

exercise price

 

Outstanding at beginning of period

    $   1,812,500  $15.97   2,250,000  $28.70 

Exercised during the period

    $   (1,125,000) $11.10     $ 

Cancelled during the period

    $     $   (437,500) $28.70 

Forfeited during the period

    $   (687,500) $11.10     $ 

Outstanding at the end of period

    $     $   1,812,500  $15.97 

Exercisable at the end of period

                1,093,750